These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2412936)

  • 1. Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients.
    Garzón P; González-Cornejo S; Román-Maldonado S; Navarro-Ruiz A
    Gen Pharmacol; 1985; 16(4):411-3. PubMed ID: 2412936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiepileptic drugs on concentration of serum proteins and immunoglobulins of epileptic patients.
    Garzón P; González-Cornejo S; Hernández-Hernández G; Aguirre-Portillo L; Almodovar-Cuevas C; Navarro-Ruiz A
    Gen Pharmacol; 1986; 17(1):49-55. PubMed ID: 3949148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
    de Wolff FA; Peters AC; van Kempen GM
    Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
    May T; Rambeck B
    Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.
    Miles MV; Snead OC; Thorn MD
    Clin Pharm; 1988 Sep; 7(9):688-93. PubMed ID: 3149223
    [No Abstract]   [Full Text] [Related]  

  • 8. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
    May TW; Rambeck B; Nothbaum N
    Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma protein binding of phenytoin in patients on valproic acid.
    Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
    Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.
    Iinuma K; Hayasaka K; Narisawa K; Tada K; Hori K
    Eur J Pediatr; 1988 Dec; 148(3):267-9. PubMed ID: 3145882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of sodium valproate, phenytoin and carbamazepine and seizure control in epilepsy.
    Goggin T; Casey C; Callaghan N
    Ir Med J; 1986 Jun; 79(6):150-6. PubMed ID: 3089966
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of serum albumin on free fractions of phenobarbital and valproic acid in patients with convulsive seizures.
    Sadahiro N; Kodama S; Matsui T; Komatsu M; Matsuo T
    Brain Dev; 1985; 7(4):377-84. PubMed ID: 3933372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.
    Kober A; Olsson Y; Sjöholm I
    Mol Pharmacol; 1980 Sep; 18(2):237-42. PubMed ID: 6775182
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring free valproic acid in epilepsy patients medicated with coanticonvulsants.
    Haidukewych D; Rodin EA
    Ther Drug Monit; 1982; 4(2):209-12. PubMed ID: 6808716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.
    Gatti G; Crema F; Attardo-Parrinello G; Fratino P; Aguzzi F; Perucca E
    Ther Drug Monit; 1987 Dec; 9(4):389-91. PubMed ID: 3122377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinicopharmacological study of serum sodium valproate free level in children with epilepsy].
    Furuya M; Hashimoto K; Kamayachi S; Fujino O
    Nihon Ika Daigaku Zasshi; 1990 Dec; 57(6):513-23. PubMed ID: 2286644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid-phenytoin interaction.
    Friel PN; Leal KW; Wilensky AJ
    Ther Drug Monit; 1979; 1(2):243-8. PubMed ID: 122160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.